Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

6.A. Round table: Personalized Prevention Roadmap for the future Healthcare (PROPHET): SRIA and implementation Roadmap

View through CrossRef
Abstract   Advancements in sequencing and genotyping technologies and the integration of digital resources in healthcare have ushered in a new era of medicine. According to PROPHET “personalised prevention aims to prevent onset, progression and recurrence of diseases through the adoption of targeted interventions that consider the biological information, environmental and behavioural characteristics, socio-economic and cultural context of individuals. This should be timely, effective and equitable to maintain the best possible balance in lifetime health trajectory”. By tailoring interventions based on risk profiles at population level, personalised prevention aims to delay disease onset, enhance quality of life and ultimately reduce the economic burden on healthcare systems. Although challenges exist in clinical implementation, genomics is the most advanced, providing examples of clinical utility such as genetic testing, polygenic risk scores, and pharmacogenomics. This SRIA considers the intricacies of the personalised prevention paradigm and elucidates the reasons for its crucial integration into European healthcare systems. After reviewing the latest research and incorporating various stakeholders’ perspectives, the SRIA identifies ten key challenges, including: The broad scope of promotion and prevention; Continuous evidence synthesis system supporting personalised prevention; The PROPHET Framework implementation; Data collection and integration, and Data Infrastructure; Community Engagement and trust; Health Professionals and Policy Makers involvement; Regulatory aspects and synergy with private sector; Access, Equity and Coverage; Ethical, Legal, Social Issues; Changing behaviour. The accompanying Roadmap provides a detailed blueprint for implementing tailored preventive strategies for each individual based on the latest scientific advancements and the specific needs of each context. The Roadmap outlines key goals, priority actions, implementation timelines, expected outcomes and output indicators, responsible entities, funding sources, and synergies with other EU initiatives, providing a structured plan for integrating personalised prevention into healthcare. For the ten challenges, we have identified 56 goals and 66 actions. These actions range from creating platforms and repositories for publications in the field of personalised prevention to improve evidence and interoperability across Europe, to the dissemination of the PROPHET framework in real-world settings, to the design and implementation of educational programs for professionals and citizens, and the establishment of regulations for data sharing and standardisation of data. The actions provide a detailed outline of what needs to be accomplished, as well as the potential obstacles that may arise. Timelines and potential funding actors have been outlined. The workshop represents the first event of dissemination of SRIA and Roadmap to the public health audience in order to gather insights and to foster the awareness of decision makers. Key messages • The SRIA on personalized prevention addresses a key action of the EU Cancer Plan and outlines ten challenges, including data collection, integration, and infrastructure. • The Roadmap represents a blueprint for the SRIA implementation through 56 goals and 66 actions, directed to decision makers at national and EU level, funders and scientists overall.
Oxford University Press (OUP)
Title: 6.A. Round table: Personalized Prevention Roadmap for the future Healthcare (PROPHET): SRIA and implementation Roadmap
Description:
Abstract   Advancements in sequencing and genotyping technologies and the integration of digital resources in healthcare have ushered in a new era of medicine.
According to PROPHET “personalised prevention aims to prevent onset, progression and recurrence of diseases through the adoption of targeted interventions that consider the biological information, environmental and behavioural characteristics, socio-economic and cultural context of individuals.
This should be timely, effective and equitable to maintain the best possible balance in lifetime health trajectory”.
By tailoring interventions based on risk profiles at population level, personalised prevention aims to delay disease onset, enhance quality of life and ultimately reduce the economic burden on healthcare systems.
Although challenges exist in clinical implementation, genomics is the most advanced, providing examples of clinical utility such as genetic testing, polygenic risk scores, and pharmacogenomics.
This SRIA considers the intricacies of the personalised prevention paradigm and elucidates the reasons for its crucial integration into European healthcare systems.
After reviewing the latest research and incorporating various stakeholders’ perspectives, the SRIA identifies ten key challenges, including: The broad scope of promotion and prevention; Continuous evidence synthesis system supporting personalised prevention; The PROPHET Framework implementation; Data collection and integration, and Data Infrastructure; Community Engagement and trust; Health Professionals and Policy Makers involvement; Regulatory aspects and synergy with private sector; Access, Equity and Coverage; Ethical, Legal, Social Issues; Changing behaviour.
The accompanying Roadmap provides a detailed blueprint for implementing tailored preventive strategies for each individual based on the latest scientific advancements and the specific needs of each context.
The Roadmap outlines key goals, priority actions, implementation timelines, expected outcomes and output indicators, responsible entities, funding sources, and synergies with other EU initiatives, providing a structured plan for integrating personalised prevention into healthcare.
For the ten challenges, we have identified 56 goals and 66 actions.
These actions range from creating platforms and repositories for publications in the field of personalised prevention to improve evidence and interoperability across Europe, to the dissemination of the PROPHET framework in real-world settings, to the design and implementation of educational programs for professionals and citizens, and the establishment of regulations for data sharing and standardisation of data.
The actions provide a detailed outline of what needs to be accomplished, as well as the potential obstacles that may arise.
Timelines and potential funding actors have been outlined.
The workshop represents the first event of dissemination of SRIA and Roadmap to the public health audience in order to gather insights and to foster the awareness of decision makers.
Key messages • The SRIA on personalized prevention addresses a key action of the EU Cancer Plan and outlines ten challenges, including data collection, integration, and infrastructure.
• The Roadmap represents a blueprint for the SRIA implementation through 56 goals and 66 actions, directed to decision makers at national and EU level, funders and scientists overall.

Related Results

Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Perceptions of Telemedicine and Rural Healthcare Access in a Developing Country: A Case Study of Bayelsa State, Nigeria
Abstract Introduction Telemedicine is the remote delivery of healthcare services using information and communication technologies and has gained global recognition as a solution to...
AL-QUR’AN: THE ONLY DIVINE GUIDANCE IN PRISTINE FORM
AL-QUR’AN: THE ONLY DIVINE GUIDANCE IN PRISTINE FORM
  Al-Qur’an is the Final divine revelation sent down to the Final Messenger of God, the Prophet Muhammad (PBUH). Allah SWT is the creator of all humankind, Jinns, and all creatures...
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Pharmacogenomics and the Concept of Personalized Medicine for the Management of Hypertension
Hypertension poses a significant global burden due to low adherence to antihypertensive medications. Hypertension treatment aims to bring blood pressure within physiological ranges...
Integrating quantum neural networks with machine learning algorithms for optimizing healthcare diagnostics and treatment outcomes
Integrating quantum neural networks with machine learning algorithms for optimizing healthcare diagnostics and treatment outcomes
The rapid advancements in artificial intelligence (AI) and quantum computing have catalyzed an unprecedented shift in the methodologies utilized for healthcare diagnostics and trea...
Violence Prevention in Healthcare Settings
Violence Prevention in Healthcare Settings
Violence is considered an important and priority public health problem that affects all healthcare professionals and has become an increasingly common and worrying phenomenon world...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...

Back to Top